alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr., Chief Justice

Stephen J. Markman

Brian K. Zahra

Bridget M. McCormack

David F. Viviano 

Richard H. Bernstein

Joan L. Larsen, Justices

I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

 October 5, 2016

t0928

Order 

Clerk

October 5, 2016

153209

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff-Appellee,

v SC: 153209

COA: 330148 

Calhoun CC: 2015-000455-FH

KEITH EDWARD WORTHINGTON,

Defendant-Appellant. 

_________________________________________/

On order of the Court, the application for leave to appeal the January 6, 2016 order 

of the Court of Appeals is considered and, it appearing to this Court that the case of 

People v Comer (Docket No. 152713) is pending on appeal before this Court and that the 

decision in that case may resolve an issue raised in the present application for leave to 

appeal, we ORDER that the application be held in ABEYANCE pending the decision in 

that case.
Exhibit 23.1**Independent Registered Public Accounting Firms’ Consent**We consent to the incorporation by reference in Registration Statement Nos. 333-98690 and 333-07191on Form S-8 of our report on the consolidated financial statements ofOakley, Inc. dated March 14, 2005 (March 31, 2006 as to the effectsof the restatement discussed in Note 16) (whichreport expresses an unqualified opinion and includes an explanatory paragraph relating to therestatement described in Note 16) and of our report on internal control over financial reportingdated March 14, 2005 (March 31, 2006 as to the effects of the material weakness described inmanagement’s report) (which report expresses an adverse opinion on the effectiveness of theCompany’s internal control over financial reporting because of a material weakness) appearing inthis Annual Report on Form 10-K/A of Oakley, Inc. for the year ended December 31, 2004./s/ DELOITTE & TOUCHECosta Mesa, California
<PAGE>   1

                                                                      EXHIBIT 23


                   [Letterhead of PricewaterhouseCoopers LLP]


                       CONSENT OF INDEPENDENT ACCOUNTANTS


         We consent to the incorporation by reference in the registration
statement of Cybex Computer Products Corporation on Form S-8 (File No.
333-10989) of our reports dated May 3, 1999, on our audits of the consolidated
financial statements and financial statement schedule of Cybex Computer Products
Corporation as of March 31, 1998 and 1999, and for each of the three years in
the period ended March 31, 1999.

PRICEWATERHOUSECOOPERS LLP

Birmingham, Alabama
June 21, 1999



                                       71
§ 26.33 Product coverage. ( a ) There are three components to this subpart each covering a discrete range of products: ( 1 ) *Quality System Evaluations.* U.S.-type surveillance/postmarket and initial/preapproval inspection reports and European Community (EC)-type quality system evaluation reports will be exchanged with regard to all products regulated under both U.S. and EC law as medical devices.
( 2 ) *Product Evaluation.* U.S.-type premarket (510(k)) product evaluation reports and EC-type-testing reports will be exchanged only with regard to those products classified under the U.S. system as Class I/Class II-Tier 2 medical devices which are listed in appendix B of this subpart.
( 3 ) *Postmarket Vigilance Reports.* Postmarket vigilance reports will be exchanged with regard to all products regulated under both U.S. and EC law as medical devices.
( b ) Additional products and procedures may be made subject to this subpart by agreement of the parties.
EXHIBIT 32

CERTIFICATIONPURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Teachers Insurance and Annuity Association of America, do hereby certify, to such officers knowledge, that:

The annual report on Form 10-K of the TIAA Real Estate Account (the Account) for the year ended December 31, 2009 (the Form 10-K) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-K fairly presents, in
  all material respects, the financial condition and results of operations of the Account.

|               |  |                                                                                                                              
|-------------- |  | -----------------------------------------------------------------------------------------------------------------------------
|March 18, 2010 |  | /s/ Roger W. Ferguson, Jr.                                                                                                   
|               |  | Roger W. Ferguson, Jr.President and Chief Executive Officer,Teachers Insurance and AnnuityAssociation of America             
|               |  |                                                                                                                              
|March 18, 2010 |  | /s/ Georganne C. Proctor                                                                                                     
|               |  | Georganne C. ProctorExecutive Vice President and Chief FinancialOfficer, Teachers Insurance and AnnuityAssociation of America

A signed original of this written statement required by Section 906 has been provided to the TIAA Real Estate Account and will be retained by the Account and furnished to the Securities and Exchange Commission or its staff upon request.

98



---
Editorial Note on Part 173
Editorial Note: Nomenclature changes to part 173 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; and 81 FR 49896, July 29, 2016.

§ 173.275 Hydrogenated sperm oil. The food additive hydrogenated sperm oil may be safely used in accordance with the following prescribed conditions: ( a ) The sperm oil is derived from rendering the fatty tissue of the sperm whale or is prepared by synthesis of fatty acids and fatty alcohols derived from the sperm whale. The sperm oil obtained by rendering is refined. The oil is hydrogenated.
( b ) It is used alone or as a component of a release agent or lubricant in bakery pans.
( c ) The amount used does not exceed that reasonably required to accomplish the intended lubricating effect.
NOz BART 24Hour Short Term Emission Rates 

at the Packaging Corporation of America 

Valdosta, Georgia Mill 

3.03 Mgal for 2-hr 47 Ib/Mgal#6 Fuel Oil 142.41 

473.00 Tons BLS/hr*22hr 0.1 Ib/MMBtu 548.68 

691.09 bared on BLS finng for 22-hrs and ad gang for 2-hrs Total 24-hr Maximum Actual 

28-80 @v;-A,3~g3& &' Ibkand glsa: emlmon rater for 24-hour arr quallly modeling Maximum Actual Hourly Average 

144.56 based on BLS finng for I-hr and 011 finng for 2-hrs Total 3-hr Maximum Actual 

48.19 6-07 IW and 9,s emlsston rater for 3 hour au quality modelrug Maximum Actual Hourly Average 

#3RFS 324.8 MMBtu/hr 3.95 Mga1124-hr 47 Ib/Mgal#6 Fuel Oil based on the maximum dally total Recovery Furnace fuel usage of 238 5 bbllday 

#3 Recovery Furnace Stack and using a rauo of tbe heat inputs to dnsmbute fuel usage 

I I 

3-hr Maximum Actual and 2Mr Maximum Actual 0.00 0.00 based on incremental increase associated with the PSOJeCl 

#2 Smelt Dissolving Tank Stack #2SDTS I I 460.14 0 Iblton BLS 0.00 0.00 tons BLSIday 0 016 lblton BLS & Tttle V Maxmmn Rocas Rate from Mlll max 24-hr period 

thmuehout I I ". 

3-hr Maximum Actual and 24-hr Maximum Actual 0.00 0.00 based an mcrememal mereax assoclaled wwlth the pmjnf 

#3 Smelt Dissolving Tank Stack #3SDTS I 652.33 0 lblton BLS 0.00 tons BLSIday 0.00 0 016 Iblton BLS Br Tltlc V Maumum Pmcers Rate ham Mlll max 24-hr penod 
SO2 BART 24-Hour Short Term Emission Rates 

at the Packaging Corporation of America 

Valdosta, Georgia Mill 

E\Cllent FderWCA\Valdorta\BART\BART Emlssbon Rates 2 02 06 dhS02 BART 

>
Editorial Note on Part 25
Editorial Note: Nomenclature changes to part 25 appear at 88 FR 45065, July 14, 2023.

§ 25.43 Records of decision. ( a ) In cases requiring environmental impact statements, at the time of its decision, the agency shall prepare a concise public record of decision.
( b ) The record of decision shall: ( 1 ) State what the decision was;
( 2 ) Identify and discuss alternatives considered by the agency in reaching its decision;
( 3 ) State whether all practicable means to avoid or minimize environmental harm have been adopted, and if not, why not; and
( 4 ) Summarize the program for monitoring and enforcing the practicable means adopted to avoid or minimize the environmental harm.
Editorial Note on Part 314
Editorial Note: Nomenclature changes to part 314 appear at 69 FR 13717, Mar. 24, 2004; 81 FR 69639, Oct. 6, 2016.

§ 314.235 Judicial review. ( a ) The Commissioner of Food and Drugs will certify the transcript and record. In any case in which the Commissioner enters an order without a hearing under § 314.200(g), the record certified by the Commissioner is required to include the requests for hearing together with the data and information submitted and the Commissioner's findings and conclusion.
( b ) A manufacturer or distributor of an identical, related, or similar drug product under § 310.6 may seek judicial review of an order withdrawing approval of a new drug application, whether or not a hearing has been held, in a United States court of appeals under section 505(h) of the act.
§ 358.303 Definitions. As used in this subpart: ( a ) *Ingrown toenail relief drug product.* A drug product applied to an ingrown toenail that relieves pain or discomfort either by softening the nail or by hardening the nail bed.
( b ) *Retainer ring.* A die cut polyethylene foam pad coated on one side with medical grade acrylic pressure-sensitive adhesive. The retainer ring has slots, center-cut completely through the foam with the cut of sufficient size to allow for localization of an active ingredient in a gel vehicle to a specific target area. The retainer ring is used with adhesive bandage strips to place over the retainer ring to hold it in place.
----

----

----

----

----

----

----

----

----

----

----

----

----

----

----

----

----

----

----

|   | CRIMSON EXPLORATION INC.                     |
|--------|----------------------------------------------|
|   |                                         |
|   | By:/s/ Allan Keel                            |
|   | Name: Allan Keel                             |
|   | Title: Chief Executive Officer and President |
|   |                                         |
|   |                                         |
|   |                                         |
|   | /s/ Carl Isaac                               |
|   | Carl Isaac                                   |
|   |                                         |
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               SEP-30-1998
<CASH>                                       1,239,591
<SECURITIES>                                    19,471
<RECEIVABLES>                                2,918,738
<ALLOWANCES>                                    50,205
<INVENTORY>                                  1,743,244
<CURRENT-ASSETS>                             5,950,648
<PP&E>                                       8,731,984
<DEPRECIATION>                               3,674,200
<TOTAL-ASSETS>                              11,143,869
<CURRENT-LIABILITIES>                        1,909,411
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     4,535,431
<OTHER-SE>                                   4,698,254
<TOTAL-LIABILITY-AND-EQUITY>                11,143,869
<SALES>                                     19,628,955
<TOTAL-REVENUES>                            20,286,131
<CGS>                                       16,930,855
<TOTAL-COSTS>                                1,723,129
<OTHER-EXPENSES>                                17,782
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              42,660
<INCOME-PRETAX>                              1,571,705
<INCOME-TAX>                                   626,000
<INCOME-CONTINUING>                            945,705
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   945,705
<EPS-PRIMARY>                                      .33
<EPS-DILUTED>                                      .32
        

</TABLE>
Exhibit 32




                Certification pursuant to 18 U.S.C. Section 1350,
                       as adopted pursuant to Section 906
                        of the Sarbanes-Oxley Act of 2002


May 15, 2006


Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549


Re:  Certification Required Under Section 906 of Sarbanes-Oxley Act of 2002

In connection with the accompanying report on Form 10-Q for the period ended
September 30, 2005, and filed with the Securities and Exchange Commission on the
date hereof (the "Report"), we, Allan D. Keel, President and CEO of Crimson
Exploration Inc. (the "Company"), and E. Joseph Grady, Senior Vice President and
Chief Financial Officer of the Company hereby certify that:

      1. The report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

       2. The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.


Crimson Exploration Inc.


/s/   Allan D. Keel
-------------------------------------------------
By: Allan D. Keel
President and Chief Executive Officer


/s/   E. Joseph Grady
-------------------------------------------------
By: E. Joseph Grady
Senior Vice President and Chief Financial Officer
Exhibit
      23.1


**Consent
      of Independent Registered Public Accounting Firm**








Astea
      International Inc. Subsidiaries


Horsham,
      Pennsylvania











We
      hereby
      consent to the incorporation by reference in the Registration Statements (Nos.
      333-33825, 333-107757, 333-34865, and 333-61981) on Form S-8 and (Nos.
      333-11949, 333-90394 and 333-17459) on Form S-3 of Astea International,
      Inc. and subsidiaries of our report dated March 24, 2006, relating to the
      consolidated financial statements of Astea International, Inc. and subsidiaries
      appearing in the Company’s Annual Report on Form 10-K for the year ended
      December 31, 2005.














BDO
      Seidman, LLP


Philadelphia,
      PA








March
      30,
      2006





70
Exhibit 15.3





Securities and Exchange Commission


100 F Street, NE


Washington, D.C. 20549





Ladies and Gentlemen:





The firm of Kost Forer Gabbay & Kasierer, A member of Ernst & Young Global, was previously the independent registered public accounting firm for Ellomay capital Ltd. (the “Company”), and reported on the financial statements of the Company for the years ended December 31, 2010 and 2009. On December 20, 2011 we were dismissed. We have read the Company’s statements included under Item 16F of its December 31, 2011 Annual Report on Form 20-F, and agree with such statements as they pertain to our firm.





Very truly yours,





/s/ Kost Forer Gabbay & KasiererKost Forer Gabbay & Kasierer,

A member of Ernst & Young GlobalTel-Aviv, Israel

April 5, 2012
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM 12/31/97
AUDITED FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                         318,766
<SECURITIES>                                         0
<RECEIVABLES>                                   17,079
<ALLOWANCES>                                     4,085
<INVENTORY>                                          0
<CURRENT-ASSETS>                               387,139
<PP&E>                                         253,025
<DEPRECIATION>                                  16,128
<TOTAL-ASSETS>                                 780,461
<CURRENT-LIABILITIES>                          101,873
<BONDS>                                        639,359
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         3,761
<OTHER-SE>                                      23,206
<TOTAL-LIABILITY-AND-EQUITY>                   780,461
<SALES>                                          5,798
<TOTAL-REVENUES>                                47,098
<CGS>                                            5,513
<TOTAL-COSTS>                                   42,719
<OTHER-EXPENSES>                                91,183
<LOSS-PROVISION>                                 3,303
<INTEREST-EXPENSE>                              39,086
<INCOME-PRETAX>                              (118,181)
<INCOME-TAX>                                     2,482
<INCOME-CONTINUING>                          (116,986)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (116,986)
<EPS-PRIMARY>                                   (3.26)
<EPS-DILUTED>                                        0


</TABLE>
June 25, 2015 

Ms. Lori Martin-Martell 

1054 NE 35 Avenue 

Homestead, FL 33033 

Dear Ms. Martin-Martell: 

This letter is to inform you that we are unable to process your request for an exemption from 

Title 14, Code of Federal Regulations (14 CFR). It explains why we can not process your 

request and what you should do in the next 30 days. 

Why We Can Not Process Your Request 

We entered your June 12, exemption request into the public docket (No. FAA-2015-2248), 

but we are unable to process your request any further. The information you sent does not 

comply with the requirements of § 11.81 (copy enclosed). For us to consider the request any 

further, you must send us all of the following: 

 The specific section or sections of 14 CFR from which you seek relief, the extent of the 

relief you seek, and the reason you seek relief. 

 The reasons why granting the request would be in the public interest; that is, how it would 

benefit the public as a whole. 

 The reasons why the exemption would not adversely affect safety or how the exemption 

would provide a level of safety at least equal to that provided by the rule from which you 

seek an exemption. 

 Any additional information, views, or arguments available to support your request. 
2 

What You Should Do 

If you want us to process your request any further, you must send the information described 

earlier to reach us within 30 days. Please note that § 11.63(d) requires you to send your 

petition for exemption at least 120 days before the proposed effective date of the exemption. 

If We Do Not Hear From You 

If we do not hear from you within 30 days, we will close the docket without notifying you 

further. If you have any questions or require additional time, you may call (202) 267-9677. 

Sincerely, 

/s/ 

Brenda Robeson 

Program Analyst, Airmen and 

 Airspace Rules Division

Enclosure
§ 520.88f Amoxicillin trihydrate tablets. ( a ) *Specifications.* Each tablet contains amoxicillin trihydrate equivalent to 50, 100, 200, or 400 milligrams (mg) amoxicillin.
( b ) *Sponsors.* See Nos. 051311 and 054771 in § 510.600(c) of this chapter.
( c ) *Conditions of use in dogs* — ( 1 ) *Amount.* Administer 5 mg per pound of body weight twice daily for 5 to 7 days or 48 hours after all symptoms have subsided.
( 2 ) *Indications for use.* For treatment of bacterial dermatitis due to *Staphylococcus aureus, Streptococcus* spp., *Staphylococcus* spp., and *Escherichia coli;* and soft tissue infections (abscesses, wounds, lacerations) due to *S. aureus, Enterococcus faecalis, E. coli, Proteus mirabilis,* and *Staphylococcus* spp.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[79 FR 28817, May 20, 2014, as amended at 83 FR 64740, Dec. 18, 2018]
SUPREME COURT OF THE STATE OF NEW YORK

Appellate Division, Fourth Judicial Department

3 

KA 11-00690 

PRESENT: SCUDDER, P.J., CENTRA, LINDLEY, SCONIERS, AND DEJOSEPH, JJ. 

 

THE PEOPLE OF THE STATE OF NEW YORK, RESPONDENT, 

V MEMORANDUM AND ORDER

DANIEL W. LEWIS, DEFENDANT-APPELLANT.

 

TIMOTHY P. DONAHER, PUBLIC DEFENDER, ROCHESTER (DREW R. DUBRIN OF

COUNSEL), FOR DEFENDANT-APPELLANT.

SANDRA DOORLEY, DISTRICT ATTORNEY, ROCHESTER (NANCY GILLIGAN OF

COUNSEL), FOR RESPONDENT. 

 

Appeal from a judgment of the Monroe County Court (Stephen T.

Miller, A.J.), rendered January 28, 2011. The judgment convicted

defendant, upon his plea of guilty, of rape in the second degree. 

It is hereby ORDERED that the judgment so appealed from is

unanimously affirmed. 

Memorandum: On appeal from a judgment convicting him, upon his

plea of guilty, of rape in the second degree (Penal Law § 130.30 [1]),

defendant contends that County Court erred in issuing an order of

protection on behalf of an individual who was the complainant with

respect to an uncharged sexual offense that was satisfied by

defendant’s plea. Defendant’s contention is unpreserved for our

review inasmuch as he “failed to challenge the issuance of the order

of protection at sentencing or to seek vacatur of the final order of

protection” (People v Morris, 82 AD3d 908, 909, lv denied 17 NY3d 808;

see People v Reynolds, 85 AD3d 825, 825-826 lv denied 18 NY3d 927). 

We reject defendant’s related contention that his challenge to the

order of protection need not be preserved because it renders his

sentence illegal. Although an order of protection is issued at

sentencing, it is not a part of a defendant’s sentence (see People v

Nieves, 2 NY3d 310, 316; People v Lilley, 81 AD3d 1448, 1448, lv

denied 17 NY3d 860). In any event, defendant waived his challenge by

agreeing to the order of protection when he pleaded guilty (see

generally People v Farewell, 90 AD3d 1502, 1503, lv denied 18 NY3d

957). 

Entered: February 13, 2015 Frances E. Cafarell

Clerk of the Court